Clinical Trial Update: Assessement of the Concordance of Genomic Alterations Between Urine and Tissue in High-Risk NMIBC Patients

View source ↗

Summary

This clinical trial evaluated the concordance of genomic alterations between urine and tissue in high-risk non-muscle-invasive bladder cancer. The study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Snippet

Sponsor: Hopital Foch | Conditions: Bladder Cancer | Status: TERMINATED